Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2
Prabha Shrestha(National Cancer Institute), Robert Yarchoan(National Cancer Institute)
Cited by 39
Related Papers
Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy
|Science Translational Medicine|2022|101